GREEN FRESH BIO (01084) announced its interim results for 2025, reporting revenue of HK$410 million, a decrease of 10.7% year-over-year. The loss attributable to owners was HK$12.068 million, representing a turn from profit to loss compared to the same period last year, with a loss per share of HK$0.014. According to the announcement, the decrease in revenue was primarily due to declining sales volume and selling prices of carrageenan and agar products during the first half of 2025, leading to reduced revenue from these products.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.